- Home
- LBTYA vs AMRX Comparison
LBTYA vs AMRX Comparison
Compare LBTYA & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LBTYA | AMRX |
|---|---|---|
| Founded | 2004 | 2002 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LBTYA | AMRX |
|---|---|---|
| Price | $10.25 | $13.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $14.77 | $13.25 |
| AVG Volume (30 Days) | ★ 1.8M | 1.6M |
| Earning Date | 02-18-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $4,770,600,000.00 | $2,934,959,000.00 |
| Revenue This Year | $15.66 | $9.99 |
| Revenue Next Year | $1.65 | $6.48 |
| P/E Ratio | ★ N/A | $714.51 |
| Revenue Growth | ★ 170.50 | 9.50 |
| 52 Week Low | $9.03 | $6.69 |
| 52 Week High | $12.09 | $13.49 |
Technical Indicators
Market Signals| Indicator | LBTYA | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 29.26 | 65.78 |
| Support Level | $10.31 | $12.66 |
| Resistance Level | $10.63 | $13.34 |
| Average True Range (ATR) | 0.27 | 0.32 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 1.40 | 87.01 |
Price Performance
Historical ComparisonAbout LBTYA Liberty Global Ltd.
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.